跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
FOSTER NEXTHALER INHALATION POWDER 200 MCG/6 MCG PER DOSE - HSA Drug Approval Details
Approvals
/
HSA
/
FOSTER NEXTHALER INHALATION POWDER 200 MCG/6 MCG PER DOSE
Approved
THERAPEUTIC
FOSTER NEXTHALER INHALATION POWDER 200 MCG/6 MCG PER DOSE
Chiesi Farmaceutici SpA
🇸🇬 Health Sciences Authority
Approval Date
Sep 25, 2024
Approval ID
5037222df04877fb
Company
Chiesi Farmaceutici SpA
Type
Therapeutic
Approval Details
Approval Id
5037222df04877fb
Drug Name
FOSTER NEXTHALER INHALATION POWDER 200 MCG/6 MCG PER DOSE
Product Name
FOSTER NEXTHALER INHALATION POWDER 200 MCG/6 MCG PER DOSE
Approval Number
SIN17099P
Approval Date
2024-09-25
Registrant
ORIENT EUROPHARMA PTE LTD
Drug Type
Therapeutic
Forensic Classification
Prescription Only
Dosage Form
AEROSOL, POWDER
Route Of Administration
RESPIRATORY (INHALATION)
Atc Code
R03AK08
Pharma Manufacturer Name
ORIENT EUROPHARMA PTE LTD
Company Detail Path
/organization/orient-europharma-pte-ltd
Active Ingredients
Beclometasone dipropionate
0.200mg/dose
Formoterol fumarate dihydrate
0.006mg/dose
Beclometasone dipropionate
0.200mg/dose
Formoterol fumarate dihydrate
0.006mg/dose
Approved
Quick Info
Agency
HSA
Country
🇸🇬
Approval Date
Sep 25, 2024
Approval ID
5037222df04877fb
Type
Therapeutic
Back to HSA Approvals
